U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Exchange Transfusion for Severe Malaria: Evidence Base and Literature Review

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Clin Infect Dis
  • Personal Author:
  • Description:
    Background.

    Exchange transfusion (ET) has biologic plausibility as an adjunct to antimalarial drugs in treating severe malaria and has been used for decades despite limited evidence of its efficacy in improving survival. We examined the efficacy of ET as an adjunct treatment for severe malaria using US surveillance data and reviewed the literature to update recommendations.

    Methods.

    Patients with severe malaria reported to the US national malaria surveillance system during 1985–2010 were matched, and survival outcomes were compared between patients receiving and not receiving ET. The literature review used search terms “severe malaria” and “exchange transfusion.” Case reports and series, observational and case-control studies, and meta-analysis were included.

    Results.

    One hundred one patients receiving ET were matched to 314 patients not receiving ET. There was no statistically significant association between ET and survival outcome (odds ratio, 0.84; 95% confidence interval, .44–1.60). We found 87 articles, mostly case reports or series, showing successful use of ET, likely reporting bias. There were 12 comparative studies, most of which were retrospective cohort studies, underpowered with no significant differences in survival. A previously published meta-analysis of 8 comparative studies found no significant survival differences. Adverse events were rarely reported but included acute respiratory distress syndrome, ventricular fibrillation, and hypotension.

    Conclusions.

    Despite rapid parasite clearance times resulting from ET, there is no evidence for efficacy of ET as adjunctive therapy in severe malaria. Adjunct ET cannot be recommended. When rapidly acting antimalarials, specifically artemisinins, become more widely available, the biologic plausibility argument for ET will become less relevant.

  • Subjects:
  • Keywords:
  • Source:
    Clin Infect Dis. 57(7):923-928
  • Pubmed ID:
    23800940
  • Pubmed Central ID:
    PMC10984079
  • Document Type:
  • Funding:
  • Volume:
    57
  • Issue:
    7
  • Collection(s):
  • Main Document Checksum:
    urn:sha256:0f260156dbc489129997f12e662be9e29fa1d3efb3863c9438238ed69df74902
  • Download URL:
  • File Type:
    Filetype[PDF - 399.08 KB ]
File Language:
English
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.